These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring. Staessen JA; Beilin L; Parati G; Waeber B; White W Blood Press Monit; 1999 Dec; 4(6):319-31. PubMed ID: 10602536 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the white-coat effect among hypertensive patients presumed to be at goal. Bookstaver DA; Hatzigeorgiou C Ann Pharmacother; 2011 Jul; 45(7-8):910-5. PubMed ID: 21750311 [TBL] [Abstract][Full Text] [Related]
10. 'Reverse white-coat hypertension' in older hypertensives. Wing LM; Brown MA; Beilin LJ; Ryan P; Reid CM; J Hypertens; 2002 Apr; 20(4):639-44. PubMed ID: 11910298 [TBL] [Abstract][Full Text] [Related]
11. Clinic and ambulatory heart rate in sustained and white-coat hypertension. Pierdomenico SD; Bucci A; Lapenna D; Cuccurullo F; Mezzetti A Blood Press Monit; 2001 Oct; 6(5):239-44. PubMed ID: 12055418 [TBL] [Abstract][Full Text] [Related]
12. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)]. Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214 [TBL] [Abstract][Full Text] [Related]
13. Is resistant hypertension really resistant? Brown MA; Buddle ML; Martin A Am J Hypertens; 2001 Dec; 14(12):1263-9. PubMed ID: 11775136 [TBL] [Abstract][Full Text] [Related]
14. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white-coat' effect. Syst-Eur investigators. Parati G; Omboni S; Staessen J; Thijs L; Fagard R; Ulian L; Mancia G J Hypertens; 1998 Jan; 16(1):23-9. PubMed ID: 9533413 [TBL] [Abstract][Full Text] [Related]
15. Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension. Muxfeldt ES; Fiszman R; de Souza F; Viegas B; Oliveira FC; Salles GF Hypertension; 2012 Feb; 59(2):384-9. PubMed ID: 22215711 [TBL] [Abstract][Full Text] [Related]